Category: Pharma Industry

Merck Fully Exempts West Virginia Providers From 340B Contract Pharmacy Restrictions

June 11, 2024 William Newton, Associate Editor/Senior Writer Views

Drug manufacturer Merck announced it will end its 340B contract pharmacy restrictions in West Virginia.

Drugmaker Merck is fully exempting West Virginia covered entities from its 340B contract pharmacy restrictions, including all data submission requirements. [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Bausch & Lomb Becomes 35th Manufacturer to Impose Contract Pharmacy Restrictions, Policy Applies to All 340B Entities

June 11, 2024 Shannon Young, Associate Editor/Senior Writer Views

Canadian drug manufacturer Bausch & Lomb announced contract pharmacy restrictions that apply to all 340B covered entity types.

Canadian drugmaker Bausch & Lomb announced last week that, beginning July 1, it will no longer offer 340B discounted products [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Alkermes Is 36th Drugmaker to Implement Contract Pharmacy Restrictions, Sanofi Tightens Policy

June 11, 2024 Rich Daly, Editor in Chief Views

Pharmaceutical manufacturer Alkermes is the 36th drugmaker to implement 340B contract pharmacy restrictions.

Irish drugmaker Alkermes will implement, on July 22, 340B contract pharmacy restrictions. The Dublin-based manufacturer is the 36th drugmaker to [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Michigan Lawmakers, Witnesses Spar Over 340B Contract Pharmacy Access Bill in Key Hearing

June 11, 2024 William Newton, Associate Editor/Senior Writer Views

Ben Frederick, associate vice president of advocacy and government relations at Memorial Healthcare, testified in support of a 340B contract pharmacy access bill at a Michigan state house hearing.

Michigan state lawmakers and representatives for drugmakers, providers, and business groups debated a 340B contract pharmacy access bill during a [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

340B Reform Could Generate Federal Savings, Says Consulting Firm That Has Conducted 340B Studies for Pharma Friendly Groups

June 11, 2024 Rich Daly, Editor in Chief Views

Avalere's Milena Sullivan told 340B Report that it's important to understand "the impact 340B reform could have on federal spending."

A federal legislative overhaul of the 340B program could provide Medicare savings for the federal government, according to a review [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Five Manufacturers Announce Refunds to 340B Providers

June 11, 2024 Rich Daly, Editor in Chief Views

Apotex Corp. announced in a July 2 notice to 340B providers that it will issue refunds to 340B covered entities that purchased any of nearly 400 products.

Five drugmakers have issued recent refund notices to 340B covered entities for drug overcharges. In letters posted on the website [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Key House Hearing Intensifies Debate on 340B’s Future Amid Multiple Major Reform Efforts

June 6, 2024 William Newton, Associate Editor/Senior Writer Views

Rep. Morgan Griffith (R-VA), chairman of the House Energy and Commerce Oversight and Investigations Subcommittee, speaks at a hearing on June 4, 2024.

A House oversight hearing this week added to the growing debate over the 340B program’s future as federal lawmakers continue [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Minnesota Is Seventh State to Enact 340B Contract Pharmacy Law, State Also Expands Covered Entity Reporting

June 6, 2024 Rich Daly, Editor in Chief Views

Minnesota Gov. Tim Walz (D) signed a law to prohibit drugmaker 340B contract pharmacy restrictions in the state.

Minnesota became the 7th state to enact a law to protect distribution of 340B drugs through contract pharmacies when the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Novartis Follows PhRMA in Seeking to Block Mississippi 340B Contract Pharmacy Law

June 6, 2024 Rich Daly, Editor in Chief Views

Drugmaker Novartis has filed the second lawsuit challenging Mississippi's 340B contract pharmacy access law.

Drugmaker Novartis recently filed the second lawsuit that seeks to block implementation and enforcement of a recently enacted Mississippi law [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

BMS Requires Re-Designation of 340B Contract Pharmacies and New Requirements Intended to Prevent Alternative Distribution Models

June 6, 2024 Rich Daly, Editor in Chief Views

Drug manufacturer BMS updated its 340B contract pharmacy restrictions to require pharmacies to re-register by June 21 and add additional requirements.

Bristol Myers Squibb (BMS) announced updates to its conditions on pharmaceutical sales involving contract pharmacies, requiring registered sites to be [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Site Footer Live